CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,214 enrolled
Drug / intervention
CardioMEMS HF Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02279888
NCT02279888N/ACompleted
CompareCT.gov

CardioMEMS HF System Post Approval Study

Abbott Medical Devices·observational·Posted Oct 31, 2014·Updated Apr 17, 2024

In Brief

An observational study evaluating CardioMEMS HF System for Heart Failure and 2 related conditions. Completed, enrolled 1,214 participants across 1 site.

Detailed Summary

The purpose of the CardioMEMS HF System Post Approval Study (PAS) is to evaluate the use of the CardioMEMS HF System in patients with NYHA class III heart failure in a commercial setting.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Left-Sided Heart Failure, Congestive Heart Failure
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 31, 2014
Enrollment StartJan 1, 2015
Primary CompletionOct 11, 2019
TodayJul 2, 2026
Enrollment to primary: 4.8 yearsPosted 11.7 years ago

Interventions

CardioMEMS HF Systemdevice

Pulmonary artery pressure sensor